USPTO serial 79235876
ALMS THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 5790339Status 709
- Filing date
- Status date
- Registration date
- Jul 2, 2019
- Examiner
- STEDMAN, CORI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALMS THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, DeLuca, & Farrell, LLP576 Broad Hollow RoadMelville, NY 11747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary products, namely, pharmaceutical and veterinary preparations for the treatment of diabetes; medications for human medicine, namely, medications for treatment of diabetes; chemical preparations for medical use, namely, chemical preparations for pharmaceutical or medical purposes, namely, for treatment of diabetes; chemical preparations for pharmaceutical use, namely, therepeutic preparations for treating diabetes; diagnosis products for medical use, namely, protein arrays for medical diagnosis purposes, chemical preparations for the diagnosis of diabetes and insulin resistance; cultures of microorganisms for medical use; stem cells for medical use; sanitary products for medical purposes, namely, sanitary preparations for medical purposes; foodstuffs and dietetic substances adapted for medical or veterinary use, namely, dietetic foods, adapted for diabetics and those with insulin resistance | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services as well as research and design relating thereto, namely, research and development services in the field of pharmacy products in the nature of medicines, research and development of new products for third parties in the field of pharmaceuticals, biological research, bacteriological research, chemical research, cosmetic science research, technical research in the field of pharmaceutical studies and food and beverage, scientific laboratory services, chemical analysis, material testing, technical project studies in the nature of engineering services, particularly technical project planning and design engineering of lines for the processing of web products, engineer's services in the nature of surveying, engineering | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Université de Strasbourg
- Other trademarks owned by Université de Strasbourg
- Other trademarks owned by Université de Strasbourg
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALMS THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 16, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 16, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jul 2, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 15, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 24, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 24, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 2, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 2, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 6, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 6, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 23, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 22, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 7, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 5, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |